                         SEQUENCE LISTING

<110>  MINERVA BIOTECHNOLOGIES CORPORATION
       BAMDAD, Cynthia
 
<120>  METHODS FOR CULTURING STEM AND PROGENITOR CELLS

<130>  13150-70100USA

<150>  US 61/186,310
<151>  2009-06-11

<150>  US 61/323,779
<151>  2010-04-13

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  45
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Primary Sequence of the MUC1 Growth Factor Receptor

<400>  1

Gly Thr Ile Asn Val His Asp Val Glu Thr Gln Phe Asn Gln Tyr Lys 
1               5                   10                  15      


Thr Glu Ala Ala Ser Arg Tyr Asn Leu Thr Ile Ser Asp Val Ser Val 
            20                  25                  30          


Ser Asp Val Pro Phe Pro Phe Ser Ala Gln Ser Gly Ala 
        35                  40                  45  


<210>  2
<211>  45
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  variant of the PSMGFR peptide

<400>  2

Gly Thr Ile Asn Val His Asp Val Glu Thr Gln Phe Asn Gln Tyr Lys 
1               5                   10                  15      


Thr Glu Ala Ala Ser Pro Tyr Asn Leu Thr Ile Ser Asp Val Ser Val 
            20                  25                  30          


Ser Asp Val Pro Phe Pro Phe Ser Ala Gln Ser Gly Ala 
        35                  40                  45  


<210>  3
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  N-10 PSMGFR

<400>  3

Gln Phe Asn Gln Tyr Lys Thr Glu Ala Ala Ser Arg Tyr Asn Leu Thr 
1               5                   10                  15      


Ile Ser Asp Val Ser Val Ser Asp Val Pro Phe Pro Phe Ser Ala Gln 
            20                  25                  30          


Ser Gly Ala 
        35  


<210>  4
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-10 PSMGFR

<400>  4

Gly Thr Ile Asn Val His Asp Val Glu Thr Gln Phe Asn Gln Tyr Lys 
1               5                   10                  15      


Thr Glu Ala Ala Ser Arg Tyr Asn Leu Thr Ile Ser Asp Val Ser Val 
            20                  25                  30          


Ser Asp Val 
        35  


<210>  5
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RGD peptide

<400>  5

His His His His His His Ser Ser Ser Ser Gly Ser Ser Ser Ser Gly 
1               5                   10                  15      


Ser Ser Ser Ser Gly Gly Arg Gly Asp Ser Gly Arg Gly Asp Ser 
            20                  25                  30      


